Abstract
An enantioselective formal synthesis of taurospongin A has been achieved. The key steps involve chelation-controlled reductions of β-ketosulfoxide and β-hydroxy ketone intermediates and Sharpless asymmetric epoxidation to construct the tertiary alcohol stereoselectively.
1. Introduction
Combination therapy consisting of both nucleoside and non-nucleoside reverse transcriptase inhibitors and protease inhibitors has become a standard treatment for HIV infection.1 Because of numerous limitations of current chemotherapies, the design and discovery of novel, structurally diverse, agents is very important.2 Taurospongin A (Fig. 1), a unique fatty acid derivative isolated from the Okinawan marine sponge Hippospon-gia sp. has very interesting biological properties:3 it inhibits DNA polymerase β and HIV reverse transcriptase with Ki values of 1.7 and 1.3 μM, respectively. The initial structure elucidation and determination of the absolute stereochemistry of taurospongin were carried out through degradation studies.3 The structural features of taurospongin A coupled with its potent reverse transcriptase inhibitory properties stimulated our interest in its synthesis and thus far, the only synthesis of (+)-taurospongin A has been reported by Lebel and Jacobsen.4 Herein, we report a stereocontrolled synthesis of the C1–C10 fragment 2 which contains all three stereocenters of taurospongin A. Segment 2 is an intermediate of the previous synthesis of (+)-taurosponginA.4 A highly stereoselective chelation-controlled reduction of an optically active β-ketosulfoxide followed by diastereoselective reduction of the resulting β-hydroxy ketone efficiently constructed the syn-1,3-diol functionality of compound 3. Sharpless epoxidation was then used to efficiently install the stereochemistry of the C3 tertiary alcohol fragment of taurospongin. The key coupling step leading to the synthesis of 2 was accomplished by opening epoxide 3 with the alkynyllithium derived from 4.
Figure 1.
2. Results and discussion
The preparation of enantiomerically pure epoxide 3 is illustrated in Scheme 1. The known5 ketal 5 was prepared in multigram quantities by heating methyl acetoacetate and ethylene glycol in dry benzene for 3 h in the presence of a catalytic amount of p-TsOH with azeotropic removal of water. Treatment of 5 with the (S)-methyl-p-tolylsulfoxide anion furnished the optically active β-ketosulfoxide 6 in 65% yield after chromatography.6 DIBAL reduction of 6 in THF at −78°C as reported by Solladie et al.7 then afforded the corresponding β-hydroxysulfoxide diastereoselectively. The 1H and 13C NMR analysis of the resulting β-hydroxysulfoxide revealed that the reduction occurred with excellent diastereoselectivity (>96% de). Removal of the ketal by exposure to oxalic acid in a mixture of THF and water furnished β-hydroxy ketone 7 in 84% yield in two steps. For syn-selective reduction of 7, we examined the chelation-controlled reduction protocol developed by Prasad and co-workers8 utilizing diethylmethoxyborane and sodium borohydride at −78°C.9 This provided the syn-1,3-diol derivative 8 as a single diastereomer (by 1H and 13C NMR analysis) in 92% isolated yield. Treatment of 8 with benzaldehyde dimethyl acetal in the presence of a catalytic amount of p-TsOH·H2O afforded the corresponding benzylidene acetal. Reduction of the resulting acetal with DIBAL effected regioselective reduction of the acetal as well as reduction of the sulfoxide moiety to the sulfide. Benzyl ether 9 was isolated in 74% yield for two steps. The β-hydroxysulfide functionality of 9 was converted to the corresponding oxirane 3 in a one pot, two-step sequence consisting of alkylation of 9 by exposure to trimethyloxoniumtetrafluoroborate in CH2Cl2 followed by treatment of the resulting mixture with aqueous potassium carbonate, providing 3 in 70% yield after chromatography.10
Scheme 1.
Reagents, conditions (and yields): (a) LDA, (S)-methyl-p-tolylsulfoxide, THF, 30 min (65%); (b) DIBAL, −78°C, THF, 30 min; (c) oxalic acid, THF/H2O, 15 h (84%, two steps); (d) Et2BOMe, NABH4, THF/MeOH, 6 h, then H2O2, 10 h (92%); (e) PhCH(OMe)2, p-TsOH·H2O, CH2Cl2, 30 min; (f) DIBAL, 0–23°C, 6 h (74%, two steps); (g) Me3OBF4, CH2Cl2; (h) K2CO3, H2O (70%, two steps).
The synthesis of compound 4 was carried out utilizing Pattenden’s protocol as shown in Scheme 2.11 The (Z)-enynol 10 was prepared in multi-gram quantities using the method described in the literature.12 Sharpless asymmetric epoxidation13 of 10 with (+)-DET provided epoxide 11 enantioselectively. The enantiomeric purity of 11 (98% ee, =−16.5 (c 0.85, CHCl3) was determined by formation of the Mosher ester and 19F NMR analysis.14 Reduction of the epoxide with LAH in ether at 0°C afforded the corresponding 1,3-diol which was treated with cyclohexanone dimethyl ketal in the presence of a catalytic amount of p-TsOH·H2O to provide ketal 4 in 71% yield from 11.
Scheme 2.
Reagents, conditions (and yields): (a) Ti(OiPr)4, (+)-DET, t-BuOOH, 4 Å MS, CH2Cl2, −30°C, 30 h (61%);(b) LAH, ether, 0°C, 1 h; (c) cyclohexanone dimethyl ketal, p-TsOH·H2O (cat.), CH2Cl2, 23°C, 3 h (71%, two steps); (d) nBuLi, BF3·OEt2, THF, −78°C, then 3, 2 h (87%); (e) Ac2O, Et3N, DMAP (cat.), CH2Cl2, 3 h (94%); (f) 10% Pd–C, H2, EtOAc, 6 h (96%); (g) TBSOTf, 2,6-lutidine, CH2Cl2, 0°C, 30 min (95%); (h) PPTS (cat.), MeOH, 15 min (95%).
Treatment of alkyne 4 with nBuLi in THF at −78°C for 20 min provided the alkynyl anion which was reacted with epoxide 3 in the presence of BF3·OEt2 at −78°C for 2 h to furnish alcohol 12 in 87% yield. Acetylation of the alcohol with acetic anhydride and triethylamine in the presence of a catalytic amount of DMAP afforded acetate 13 in 94% yield. Hydrogenation of 13 over 10% Pd–C in ethyl acetate effected saturation of the triple bond as well as removal of the benzyl group to afford alcohol 14. It was converted to TBS ether 15 by reaction with TBSOTf in the presence of 2,6-lutidine at 0°C for 30 min. Exposure of 15 to PPTS in methanol at 23°C for 15 min removed the cyclohexylidene ketal and provided diol 2 which has been converted previously to (+)-taurospongin by Lebel and Jacobsen.4 Spectral data (1H and 13C NMR) for synthetic 2 =−3.8 (c 1.58, CHCl3), lit. =−2.5 (c 1.73, CHCl3) are in full agreement with those reported in the literature.4
3. Conclusion
In conclusion, an enantioselective formal synthesis of (+)-taurospongin A has been accomplished utilizing chelation-controlled reduction and Sharpless asymmetric epoxidation as the key steps. The present synthesis will provide further access to structural variants of taurospongin A for important structure–activity studies.
4. Experimental
All moisture sensitive reactions were carried out under argon or nitrogen atmosphere. Anhydrous solvents were obtained as follows: tetrahydrofuran and diethyl ether, distilled from sodium and benzophenone; dichloromethane, distilled from CaH2; triethylamine, distilled from CaH2. All other solvents were HPLC grade. Column chromatography was performed with Whatman 240–400 mesh silica gel under low pressure of 5–10 psi. Thin-layer chromatography (TLC) was carried out with E. Merck silica gel 60 F-254 plates. 1H and 13C NMR spectra were recorded on Bruker Avance 400 (400 MHz), Avance 500 (500 MHz) and Varian 300 (300 MHz) spectrometers.
4.1. (S)-4,4-(Ethylenedioxy)-1-(p-tolylsulfinyl)pentan-2-one, 6
To a stirred solution of LDA [prepared from iPr2NH (2.2 mL, 15.4 mmol) and nBuLi (8.1 mL, 13.0 mmol)] in THF at 0°C was added (S)-methyl-p-tolylsulfoxide (Aldrich, 0.91 g, 5.9 mmol) in THF (5 mL). The resulting mixture was stirred for 30 min at 0°C and added to a solution of methyl ester 5 (0.98 g, 6.1 mmol) in THF (15 mL). The reaction mixture was stirred at room temperature for 30 min and quenched with saturated aqueous NH4Cl. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over Na2SO4 and evaporated under reduced pressure. The residue was purified by column chromatography (50% EtOAc in hexanes) to provide the title compound (1.08 g, 65% yield) as a colorless oil. =−153 (c 0.81, CHCl3); IR (film): 2981, 2893, 1710, 1040 cm−1; 1H NMR (300 MHz, CDCl3): δ 1.25 (s, 3H), 2.33 (s, 3H),2.74 (ABq, 2H, J=13.2, Δv=28.6 Hz), 3.84–3.91 (m, 6H), 7.25 (d, 2H, J=7.8 Hz), 7.47 (d, 2H, J=8.4 Hz); 13C NMR (75 MHz, CDCl3): δ 21.1, 24.2, 52.9, 64.2,64.3, 68.6, 107.2, 123.8, 129.7, 139.5, 141.7, 198.9
4.2. (2R,SS)-2-Hydroxy-1-(p-tolylsulfinyl)pentan-4-one, 7
To a stirred solution of 6 (660 mg, 2.33 mmol) in THF (30 mL) at −78°C was added DIBAL (4.67 mL 1 M solution in hexane, 4.67 mmol) dropwise. The resulting mixture was stirred for 30 min and quenched with methanol and warmed to room temperature. The solvent was removed under reduced pressure and the residue was dissolved in EtOAc and 10% aqueous potassium sodium tartrate solution. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over Na2SO4 and evaporated under reduced pressure to provide crude β-keto-α-hydroxysulfoxide. An analytical sample was prepared after column chromatography over silica gel (25% ethyl acetate in hexanes). 1H NMR (400 MHz, CDCl3): δ 1.32 (s, 3H),1.86 (dd, 1H, J=14.5, 3.8 Hz), 1.91 (dd, 1H, J=14.5,7.9 Hz), 2.41 (s, 3H), 2.79 (dd, 1H, J=13.0, 3.0 Hz),2.86 (dd, 1H, J=13.0, 9.5 Hz), 3.89–4.00 (m, 5H),4.46–4.54 (m, 1H), 7.33 (d, 2H, J=8.4 Hz), 7.55 (d, 2H, J=8.1 Hz); 13C NMR (100 MHz, CDCl3): δ 21.4, 24.1,44.5, 63.0, 64.3, 64.5, 109.6, 123.9, 129.9, 140.7, 141.4.
To a stirred solution of the above alcohol in THF (5 mL) and H2O (10 mL) was added oxalic acid (581.1 mg, 4.6 mmol). The resulting mixture was stirred at room temperature for 15 h and quenched with saturated aqueous NaHCO3. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over Na2SO4 and evaporated under reduced pressure. The crude product was washed with ether to provide β-hydroxy ketosulfoxide 7 as a white solid (406 mg, 84% two steps). Mp 105°C; =−305 (c 0.34, CHCl3); IR (film): 3379, 2921, 1710, 1084 cm−1; 1H NMR (300 MHz, CDCl3): δ 2.05 (s, 3H), 2.28 (s, 3H), 2.51–2.67 (m, 2H), 2.71–2.89 (m, 2H), 4.53–4.60 (m, 1H), 4.76 (br, 1H), 7.20 (d, 2H, J=7.8 Hz), 7.44 (d, 2H, J=7.8 Hz); 13C NMR (75 MHz, CDCl3): δ 21.0, 30.4, 49.4, 62.3,63.0, 123.6, 129.7, 139.7, 141.2, 207.1
4.3. (2R,4S,SS)-2,4-Dihydroxy-1-(p-tolylsulfinyl)pentane, 8
To a stirred solution of 7 (257 mg, 1.1 mmol) in THF (20 mL) and methanol (4 mL) was added diethylmethoxyborane (0.17 mL, 1.3 mmol). After stirring for 15 min at room temperature, the reaction mixture was cooled to −78°C and sodium borohydride (57 mg, 1.5 mmol) was added. The reaction mixture was stirred at −78°C for additional 6 h and 50% aqueous H2O2 (0.5 mL) was added. The mixture was warmed to room temperature and diluted with EtOAc and H2O. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with saturated NaHCO3, Na2SO3, brine, dried over Na2SO4 and evaporated under reduced pressure. The resulting white solid (236 mg, 92% yield) was sufficiently pure to be used for next step reaction without further purification. Mp 122°C; =−291 (c 1.01, CHCl3); IR (film): 3370, 2966, 2922, 1066, 1028, 1010 cm−1; 1H NMR (400 MHz, CDCl3): δ 1.12 (d, 3H, J=6.2 Hz), 1.48 (dt, 1H, J=14.2, 3.0 Hz), 1.64 (dt, 1H, J=14.2, 9.5 Hz), 2.35 (s, 3H), 2.74 (dd, 1H, J=13.2,2.3 Hz), 2.87 (dd, 1H, J=13.2, 9.9 Hz), 3.99–4.03 (m, 1H), 4.21 (s, 1H), 4.38–4.44 (m, 1H), 5.30 (d, 1H, J=3.0 Hz), 7.27 (d, 2H, J=8.2 Hz), 7.48 (d, 2H, J=8.2 Hz); 13C NMR (100 MHz, CDCl3): δ 21.3, 23.8, 44.4,64.4, 66.3, 67.5, 123.9, 130.0, 139.8, 141.6; HRMS (EI) m/z calcd for C12H18O3NaS (M++Na): 265.0874; found: 265.0874.
4.4. (2R,4S)-4-Benzyloxy-2-hydroxy-1-(mercapto-p-tolyl)pentane, 9
To a stirred solution of 8 (191 mg, 0.79 mmol) in CH2Cl2 (10 mL) was added benzaldehyde dimethyl acetal (0.24 mL, 1.6 mmol) and p-TsOH·H2O (15 mg, 0.1 mmol). The resulting mixture was stirred for 1 h and quenched with saturated NaHCO3. The layers were separated and the aqueous layer was extracted with CH2Cl2. The combined organic layers were washed with brine, dried over Na2SO4 and evaporated under reduced pressure. The residue was purified by column chromatography (50% EtOAc in hexanes) to provide the corresponding benzylidene acetal. 1H NMR (500 MHz, CDCl3): δ 1.33 (d, 3H, J=6.2 Hz), 1.48 (dt, 1H, J=13.0, 11.1 Hz), 1.65 (dt, 1H, J=13.0, 2.4 Hz), 2.41 (s, 3H), 2.85–2.94 (m, 2H), 4.01–4.01 (m, 1H), 4.50–4.55 (m, 1H), 5.67 (s, 1H), 7.31–7.56 (m, 9H); 13C NMR (125 MHz, CDCl3): δ 21.8, 21.9, 38.5, 64.9, 70.9, 73.2, 101.0, 124.2, 126.5, 128.6, 129.2, 130.4, 138.5, 141.5, 141.9.
The above benzylidene acetal was dissolved in CH2Cl2 (20 mL) and cooled to 0°C. DIBAL (7.9 mL, 1 M solution in hexane, 7.9 mmol) was added dropwise. The resulting mixture was warmed to room temperature and stirred for an additional 6 h. The reaction mixture was quenched with 1N HCl. The layers were separated and the aqueous layer was extracted with CH2Cl2. The combined organic layers were washed with saturated NaHCO3, brine, dried over Na2SO4 and evaporated under reduced pressure. The residue was purified by column chromatography (30% EtOAc in hexanes) to provide 9 as a colorless oil (176 mg, 74%). =−36.5 (c 0.46, CHCl3); IR (film): 3421, 2921, 1641 cm−1; 1H NMR (500 MHz, CDCl3): δ 1.25 (d, 3H, J=6.1 Hz),1.73–1.84 (m, 2H), 2.35 (s, 3H), 2.93 (dd, 1H, J=13.4,5.9 Hz), 3.00 (dd, 1H, J=13.4, 6.6 Hz), 3.78–3.82 (m, 1H), 3.90–3.93 (m, 1H), 4.40 (d, 1H, J=11.4 Hz), 4.64 (d, 1H, J=11.4 Hz), 7.09 (d, 2H, J=7.9 Hz), 7.28–7.34 (m, 7H); 13C NMR (125 MHz, CDCl3): δ 20.0, 21.4,42.0, 42.9, 70.0, 70.7, 75.6, 128.2, 128.9, 130.1, 130.3, 130.5, 132.6, 136.7, 138.4; HRMS (EI) m/z calcd for C19H24O2NaS (M++Na): 339.1395; found: 339.1406.
4.5. (2R,4S)-4-Benzyloxy-1,2-epoxypentane, 3
To a stirred solution of 9 (54 mg, 0.18 mmol) in CH2Cl2 (4 mL) was added trimethyloxonium tetrafluoroborate (32 mg, 0.22 mmol) and the resulting mixture was stirred for 2 h at room temperature. An aqueous solution of K2CO3 (50 mg in 2 mL H2O) was added and stirring was continued for 30 h. The aqueous layer was extracted with CH2Cl2. The combined organic layers were washed with brine, dried over Na2SO4 and evaporated under reduced pressure. The residue was purified by column chromatography (15% EtOAc in hexanes) to provided 3 as a colorless oil (24 mg, 70% for two steps). =−20.1 (c 0.69, CHCl3); IR (film): 2918, 2854, 1452, 1064 cm−1; 1H NMR (500 MHz, CDCl3): δ 1.29 (d, 3H, J=6.2 Hz), 1.69 (dt, 1H, J=14.2, 5.5 Hz), 1.87 (dt, 1H, J=14.2, 6.2 Hz), 2.48 (dd, 1H, J=5.0, 2.7 Hz),2.75 (t, 1H, J=4.7 Hz), 3.05 (m, 1H), 3.74 (m, 1H),4.48 (d, 1H, J=11.7 Hz), 4.60 (d, 1H, J=11.7 Hz),7.32–7.35 (m, 5H), 13C NMR (125 MHz, CDCl3): δ20.0, 39.7, 47.2, 50.0, 70.7, 73.0, 127.9, 127.9, 128.7, 139.1; HRMS (EI) m/z calcd for C12H16O2Na (M++Na): 215.1048; found: 215.1050.
4.6. (2S,3R)-3-Ethynyl-3-methyloxiranyl)methanol, 11
To a stirred suspension of powdered 4 Å molecular sieves (1.5 g) in CH2Cl2 (60 mL) cooled at −23°C were sequentially added (+)-DET (0.5 mL 2.8 mmol), Ti(OiPr)4 (0.69 mL, 2.3 mmol) and the resulting mixture was stirred for 20 min at −23°C. After this period, a solution of (Z)-3-methylpent-2-en-4-yn-1-ol 10 (1.5 g, 15.6 mmol) dissolved in CH2Cl2 (10 mL) was added dropwise. After 20 min, TBHP (10.4 mL, 3.3 M solution in benzene, 34.4 mmol) was added and the resulting mixture was kept at −23°C for 30 h. After this period, 30% aqueous NaOH (20 mL) was added and the mixture was stirred at 0°C for 1 h. The resulting suspension was filtered through Celite. The filtrate was diluted with H2O and EtOAc. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The residue oil was purified by column chromatography (30% EtOAc in hexanes) to provide compound 11 as a colorless oil (1.07 g, 61%). =−16.5 (c 0.85 CHCl3); IR (film): 3396, 2982, 2359, 1444, 1381, 1017 cm−1; 1H NMR (300 MHz, CDCl3): δ 1.53 (s, 3H),2.39 (s, 1H), 2.82 (br, 1H), 3.07 (dd, 1H, J=6.3, 4.8 Hz), 3.76 (dd, 1H, J=12.3, 6.3 Hz), 3.88 (dd, 1H, J=12.3, 4.8 Hz); 13C NMR (75 MHz, CDCl3): δ 22.7,51.2, 61.9, 63.5, 72.9, 80.4; MS (ESI) m/z 135.0 (M++Na).
4.7. (S)-3-Methyl-1,3-O-cyclohexylidenepent-4-yne, 4
To a stirred solution of epoxide 11 (0.96 g, 8.6 mmol) in ether (20 mL) at 0°C was added LiAlH4 (812 mg, 21.4 mmol). After stirring at 0°C for one hour, the reaction was quenched with 10% aqueous potassium sodium tartrate solution. The layers were separated and the aqueous layer was saturated with NaCl and extracted with EtOAc. The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure. The residue oil was purified by column chromatography (45% EtOAc in hexanes) to provide the corresponding diol as a colorless oil (0.91 g, 93%). =−6.0 (c 1.0 CHCl3); IR (film): 3344, 2980, 1417, 1373, 1133, 1094, 1053 cm−1; 1H NMR (300 MHz, CDCl3): δ 1.47 (s, 3H), 1.76 (td, 1H, J=14.4, 3.9 Hz),1.93 (ddd, 1H, J=14.4, 9.4, 4.8 Hz), 2.46 (s, 1H), 3.83 (td, 1H, J=11.4, 4.8 Hz), 4.18–4.23 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 30.1, 43.0, 59.8, 68.1, 71.6, 86.7; MS (ESI) m/z 81.0, 137.1 (M++Na).
To a stirred solution of the above diol (730 mg, 6.4 mmol) in CH2Cl2 (40 mL) was added cyclohexanone dimethyl ketal (2.14 mL, 14.0 mmol) and p-TsOH·H2O (121.8 mg, 0.64 mmol). The resulting mixture was stirred for 3 h and quenched with saturated aqueous NaHCO3. The layers were separated and the aqueous layer was extracted with CH2Cl2. The combined organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The residue oil was purified by column chromatography (5% EtOAc in hexanes) to provide compound 4 as a colorless oil (944 mg, 76%). =+10.0 (c 1.0 CHCl3); IR (film): 3305, 2935, 1368, 1123, 1094, 948 cm−1; 1H NMR (500 MHz, CDCl3): δ 1.32–1.37 (m, 4H), 1.45 (s, 3H), 1.48–1.55 (m, 6H), 1.64 (td, 1H, J=13.2, 2.2 Hz), 1.82 (dt, 1H, J=12.9, 5.0 Hz), 2.37 (s, 1H), 3.77 (ddd, 1H, J=12.0,5.1, 1.8 Hz), 4.24 (dt, 1H, J=12.0, 2.4 Hz); 13C NMR (125 MHz, CDCl3): δ 22.7, 22.9, 25.6, 30.7, 32.4, 37.5,39.6, 56.7, 65.4, 71.8, 88.2, 100.0; MS (ESI) m/z 233.1 (M++K).
4.8. (3S,7S,9R)-9-Benzyloxy-7-hydroxy-1,3-O-cyclohexylidene-3-methyldec-4-yne, 12
To a stirred solution of alkyne 4 (242 mg, 0.62 mmol) in THF (5 mL) cooled to −78°C was added nBuLi (0.82 mL, 1.6 M solution in hexane, 1.30 mmol) dropwise. After stirring for 20 min, BF3·OEt2 (0.16 mL, 1.30 mmol) and (2R,4S)-4-benzyloxy-1,2-epoxypentane 3 (119 mg, 0.62 mmol) dissolved in THF (1 mL) were sequentially added. The reaction mixture was stirred at −78°C for 2 h and quenched with saturated aqueous NH4Cl. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The residue oil was purified by column chromatography (15% EtOAc in hexanes) to provide 12 as a colorless oil (208 mg, 87%). =−29.4 (c 1.7 CHCl3); IR (film): 3468, 2933, 2861, 1449, 1123, 1094, 945 cm−1; 1H NMR (500 MHz, C6D6): δ 1.06 (dd, 3H, J=6.0, 2.7 Hz), 1.44–1.58 (m, 4H), 1.63 (s, 3H), 1.68–1.97 (m, 10H), 2.37 (td, 1H, J=16.4, 7.6 Hz), 2.49 (ddd, 1H, J=16.4, 5.2, 1.4 Hz),2.58 (br, 1H), 3.55–3.63 (m, 1H), 3.71–3.75 (m, 1H),3.97–4.01 (m, 1H), 4.16 (dd, 1H, J=11.7, 2.2 Hz),4.31–4.39 (m, 1H), 4.41 (d, 1H, J=11.7 Hz), 7.22–7.30 (m, 5H); 13C NMR (125 MHz, C6D6): δ 19.7, 23.3,23.8, 26.4, 28.2, 31.7, 33.2, 38.5, 40.6, 43.5, 53.4, 57.2,66.3, 70.4, 75.5, 81.1, 86.9, 99.8, 128.2, 128.4, 128.9, 138.8; MS (ESI) m/z 409.3 (M++Na).
4.9. (3S,7S,9R)-7-Acetoxy-9-benzyloxy-1,3-O-cyclohexylidene-3-methyldec-4-yne, 13
To a stirred solution of alcohol 12 (122 mg, 0.31 mmol) in CH2Cl2 (5 mL) were sequentially added triethylamine(0.12 mL, 0.93 mmol), acetic anhydride (74 mL, 0.78 mmol) and 4-dimethylaminopyridine (18.9 mg, 0.15 mmol). The reaction mixture was stirred for 3 h and quenched with aqueous saturated NH4Cl. The layers were separated and the aqueous layer was extracted with CH2Cl2. The combined organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The residue oil was purified by column chromatography (10% EtOAc in hexanes) to provide 13 as a colorless oil (125 mg, 94%). =+13.9 (c 1.8 CHCl3); IR (film): 2932, 2360, 1739, 1372, 1195 cm−1; 1H NMR (500 MHz, CDCl3): δ 1.23 (dd, 3H, J=6.1, 1.1 Hz), 1.35–1.43 (m, 2H), 1.45 (s, 3H),1.51–1.64 (m, 7H), 1.77–1.86 (m, 2H), 1.98 (s, 3H),1.99–2.04 (m, 1H), 2.2 (br, 2H), 2.40 (dd, 1H, J=16.9,5.3 Hz), 2.50 (ddd, 1H, J=16.9, 5.8, 3.5 Hz), 3.56–3.60 (m, 1H), 3.74–3.78 (m, 1H), 4.16–4.23 (m, 1H), 4.41 (d, 1H, J=11.7 Hz), 4.57 (d, 1H, J=11.7 Hz), 5.03–5.06 (m, 1H), 7.29–7.34 (m, 5H); 13C NMR (125 MHz, CDCl3): δ 19.9, 21.5, 23.1, 23.5, 24.7, 26.0, 31.2, 33.0,38.3, 40.2, 40.3, 57.4, 66.1, 70.0, 70.5, 72.1, 79.4, 86.8,99.8, 127.9, 128.0, 128.7, 138.9, 170.7; MS (ESI) m/z 271.1, 451.3 (M++Na).
4.10. (3R,7S,9R)-7-Acetoxy-1,3-O-cyclohexylidene-9-hydroxy-3-methyldecane, 14
A solution of 13 (90 mg, 0.21 mmol) in EtOAc (10 mL) containing Pd/C (18 mg) was put under a H2 balloon. The solution was stirred for 6 h and filtered through Celite. The filtrate was concentrated under reduced pressure and the residue oil was purified by column chromatography (35% EtOAc in hexanes) to provide the title compound as a colorless oil (68.9 mg, 96%). =−5.3 (c 1.5 CHCl3); IR (film); 3454, 2934, 2859, 1735, 1246, 1107 cm−1; 1H NMR (500 MHz, C6D6): δ 1.18 (d, 3H, J=6.0 Hz), 1.24 (s, 3H), 1.32–1.77 (m, 18H), 1.71 (s, 3H), 1.93–1.98 (m, 2H), 3.51–3.59 (m, 1H), 3.65–3.88 (m, 2H), 5.22–5.28 (m, 1H); 13C NMR (125 MHz, C6D6): δ 19.2, 20.6, 23.2, 23.4, 25.8, 26.8,30.0, 34.3, 35.1, 36.0, 38.6, 43.9, 44.1, 55.7, 65.2, 71.7,72.1, 97.8, 170.1; MS (ESI) m/z 285.7, 365.2 (M++Na).
4.11. (3R,7S,9R)-7-Acetoxy-9-O-tert-butyldimethylsilyl-1,3-O-cyclohexylidene-3-methyldecane, 15
To a stirred solution of 14 (64.5 mg, 0.19 mmol) in CH2Cl2 (3 mL) was added 2,6-lutidine (33 mL, 0.29 mmol) and TBSOTf (50 mL, 0.23 mmol). The reaction mixture was stirred for 30 min and quenched with saturated aqueous NH4Cl. The layers were separated and the aqueous layer was extracted with CH2Cl2. The combined organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The residue oil was purified by column chromatography (10% EtOAc in hexanes) to provide compound 15 as a colorless oil (83 mg, 95%). =−1.3 (c 1.5, CHCl3); IR (film): 2933, 2857, 1738, 1463, 1246, 1135, 1108 cm−1; 1H NMR (500 MHz, C6D6): δ 0.17 (s, 3H),0.20 (s, 3H), 1.10 (s, 9H), 1.11 (d, 3H, J=6.0 Hz), 1.20 (s, 3H), 1.26–1.31 (m, 5H), 1.59–1.74 (m, 12H), 1.84 (s, 3H), 1.96–2.05 (m, 3H), 3.69–3.74 (m, 1H), 3.77–3.83 (m, 1H), 3.96–4.00 (m, 1H), 5.33–5.36 (m, 1H); 13C NMR (125 MHz, C6D6): δ −5.3, −3.9, 14.5, 18.4, 19.6,20.9, 23.6, 23.9, 26.2, 27.1, 30.3, 34.9, 35.7, 36.4, 39.1,44.7, 45.2, 56.1, 66.4, 70.6, 72.1, 98.2, 170.0; MS (ESI) m/z 184.0, 341.1, 479.3 (M+Na)+; HRMS (EI) m/z calcd for C25H48O5NaSi (M++Na): 479.3161; found: 479.6164.
4.12. (3R,7S,9R)-7-Acetoxy-9-O-tert-butyldimethylsilyl-3-methyldecane-1,3-diol, 2
To a stirred solution of 15 (42 mg, 0.09 mmol) in MeOH (3 mL) was added PPTS (5.1 mg, 0.02 mmol). The reaction mixture was stirred for 15 min and quenched with saturated aqueous NaHCO3 and diluted with EtOAc. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The residue oil was purified by column chromatography (50% EtOAc in hexanes) to provide 2 as a colorless oil (33 mg, 95%). =−3.8 (c 1.58 CHCl3); IR (film): 3380, 2955, 2930, 2860, 1740, 1460, 1375, 1250, 1140 cm−1; 1H NMR (500 MHz, CDCl3): δ 0.05 (s, 6H), 0.88 (s, 9H), 1.15 (d, 3H, J=6.1 Hz), 1.22 (s, 3H), 1.23–1.37 (m, 2H), 1.46–1.59 (m, 5H), 1.60–1.67 (m, 1H), 1.75–1.90 (m, 2H), 2.03 (s, 3H), 2.45 (s, 2H), 3.80–3.93 (m, 3H), 4.95–5.01 (m, 1H); 13C NMR (125 MHz, CDCl3): δ −4.4, −3.9, 18.5, 20.9, 21.8, 23.8, 26.2, 27.1, 35.3, 41.8,42.0, 44.7, 60.3, 66.0, 71.9, 74.0, 171.1; HRMS (EI) m/z calcd for C19H40O5NaSi (M++Na): 399.2543; found: 399.2547.
Acknowledgements
Financial support for this work was provided by the National Institutes of Health. We thank Dr. Geoffrey Bilcer for helpful discussions and Mr. Joseph T. Kim for experimental assistance.
References
- 1.Flexner C New Engl. J. Med 1998, 338, 1281. [DOI] [PubMed] [Google Scholar]
- 2.Cihlar T; Bischofberger NN Ann. Rep. Med. Chem 2000, 35, 177. [Google Scholar]
- 3.Ishiyama H; Ishibashi M; Ogawa A; Yoshida S; Kobayashi JJ Org. Chem 1997, 62, 3831. [Google Scholar]
- 4.Lebel H; Jacobsen EN J. Org. Chem 1998, 63, 9624. [Google Scholar]
- 5.Cavallaro RA; Filocamo L; Galuppi A; Galione A; Brufani M; Genazzani AA J. Med. Chem 1999, 42, 2527. [DOI] [PubMed] [Google Scholar]
- 6.Solladie G; Greck C; Demailly G; Solladie-Cavallo A Tetrahedron Lett 1982, 23, 5047. [Google Scholar]
- 7.(a) For application of this protocol, see: Solladie G; Salom-Roig XJ; Hanquet G Tetrahedron Lett 2000, 41, 551; [Google Scholar]; (b) Solladie G; Ghiatou N Bull. Chim. Soc. Fr 1994, 131, 575 and references cited therein. [Google Scholar]
- 8.Chen K-M; Hardtmann GE; Prasad K; Repic O; Shapiro M Tetrahedron Lett 1987, 28, 155. [Google Scholar]
- 9.(a) For other related reductions, see: Narasaka K; Pai FC Tetrahedron 1984, 40, 2233; [Google Scholar]; (b) Kathawala FG; Prager B; Prasad K; Repic O; Shapiro MJ; Stabler RS; Widler L Helv. Chim. Acta 1986, 69, 803. [Google Scholar]
- 10.(a) Ma P; Martin VS; Masamune S; Sharpless KB; Viti SM J. Org. Chem 1982, 47, 1378; [Google Scholar]; (b) Fugisawa T; Sato T; Kawara T; Ohashi K Tetra-hedron Lett 1981, 22, 4823 and references cited therein. [Google Scholar]
- 11.Pattenden G; Cid MB Synlett 1998, 540. [Google Scholar]
- 12.Mori K; Ohki M; Sato A; Matsui M Tetrahedron 1972, 28, 3739. [Google Scholar]
- 13.Johnson RA; Sharpless KB In Catalytic Asymmetric Synthesis; Ojima I, Ed.; VCH: New York, 1993; p. 103. [Google Scholar]
- 14.Dale JA; Dull DL; Mosher HS J. Org. Chem 1969, 34, 2543. [Google Scholar]